Alexza Pharmaceuticals, Inc. (ALXA) Posts Q2 EPS Loss of $0.13
Tweet
Share
E-mailGet Alerts ALXA Hot Sheet
Price: $0.92 --0%
Financial Fact:
Net loss attributable to Alexza common stockholders: -3.02M
Today's EPS Names:
MAXN, CSTR, ACU, More
Financial Fact:
Net loss attributable to Alexza common stockholders: -3.02M
Today's EPS Names:
MAXN, CSTR, ACU, More
Join SI Premium – FREE
Alexza Pharmaceuticals, Inc. (NASDAQ: ALXA) reported Q2 EPS of ($0.13), $0.02 better than the analyst estimate of ($0.15). Revenue for the quarter came in at $1.26 million versus the consensus estimate of $430 thousand.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- American Express (AXP) down despite beating Q1 estimates on top and bottom lines
- Schlumberger (SLB) earnings in-line, revenue beats expectations
- PPG Industries (PPG) Reports In-Line Q1 EPS, offers outlook
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
